[Echocardiography in cardiac arrhythmias].
Echokardiographie in der Rhythmologie.
Atrial fibrillation ablation
Cardiac tamponade
Ejection fraction
Left atrial thrombus
Transseptal puncture
Journal
Herzschrittmachertherapie & Elektrophysiologie
ISSN: 1435-1544
Titre abrégé: Herzschrittmacherther Elektrophysiol
Pays: Germany
ID NLM: 9425873
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
03
07
2023
accepted:
19
07
2023
medline:
29
8
2023
pubmed:
16
8
2023
entrez:
16
8
2023
Statut:
ppublish
Résumé
Echocardiography plays a key role in planning and guidance of electrophysiological procedures. After exclusion of structural heart disease, echocardiography provides insight into the extent of left atrial remodeling by determining left atrial metrics. This "biomarker" is associated with the risk of new-onset atrial fibrillation and predictive of atrial fibrillation recurrence after ablation. Transesophageal echocardiography is necessary to exclude left atrial thrombi and is able to guide a transseptal puncture. In case of a rare but life-threatening cardiac tamponade, an echocardiographic-guided pericardiocentesis ensures quick and effective treatment. Left ventricular ejection fraction and deformation analysis determined by echocardiography are established methods for risk stratification in patients with systolic dysfunction and used to guide pharmacological and device therapy. Die Echokardiographie spielt bei der Planung und Durchführung von elektrophysiologischen Eingriffen eine zentrale Rolle. Neben dem Ausschluss struktureller Herzerkrankungen gestattet die Echokardiographie durch die Bestimmung der linksatrialen Größe und Funktion einen Einblick in das Ausmaß des linksatrialen Remodelings. Dieser Biomarker ist mit dem Risiko von neu auftretendem Vorhofflimmern verbunden und prädiktiv für den Erfolg einer Vorhofflimmerablation. Die transösophageale Echokardiographie erlaubt den Ausschluss von linksatrialen Thromben und prozedurbegleitend die Steuerung einer transseptalen Punktion. Im Fall einer seltenen aber lebensbedrohlichen Perikardtamponade ermöglicht eine echokardiographisch gesteuerte Perikardpunktion eine schnelle und effektive Behandlung. Die echokardiographisch bestimmte linksventrikuläre Ejektionsfraktion und Deformationsanalyse sind etablierte Methoden zur Risikostratifizierung von Patienten mit eingeschränkter Pumpfunktion und dienen zur Planung einer Pharmako- und Devicetherapie.
Autres résumés
Type: Publisher
(ger)
Die Echokardiographie spielt bei der Planung und Durchführung von elektrophysiologischen Eingriffen eine zentrale Rolle. Neben dem Ausschluss struktureller Herzerkrankungen gestattet die Echokardiographie durch die Bestimmung der linksatrialen Größe und Funktion einen Einblick in das Ausmaß des linksatrialen Remodelings. Dieser Biomarker ist mit dem Risiko von neu auftretendem Vorhofflimmern verbunden und prädiktiv für den Erfolg einer Vorhofflimmerablation. Die transösophageale Echokardiographie erlaubt den Ausschluss von linksatrialen Thromben und prozedurbegleitend die Steuerung einer transseptalen Punktion. Im Fall einer seltenen aber lebensbedrohlichen Perikardtamponade ermöglicht eine echokardiographisch gesteuerte Perikardpunktion eine schnelle und effektive Behandlung. Die echokardiographisch bestimmte linksventrikuläre Ejektionsfraktion und Deformationsanalyse sind etablierte Methoden zur Risikostratifizierung von Patienten mit eingeschränkter Pumpfunktion und dienen zur Planung einer Pharmako- und Devicetherapie.
Identifiants
pubmed: 37584761
doi: 10.1007/s00399-023-00956-1
pii: 10.1007/s00399-023-00956-1
doi:
Types de publication
English Abstract
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
256-264Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M, Pennock GD, Safford RE, Rothbart RM, Halperin JL, Hart RG (1999) Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 137:494–499. https://doi.org/10.1016/s0002-8703(99)70498-9
doi: 10.1016/s0002-8703(99)70498-9
pubmed: 10047632
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru M, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39. https://doi.org/10.1016/j.echo.2014.10.003
doi: 10.1016/j.echo.2014.10.003
pubmed: 25559473
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373–498. https://doi.org/10.1093/eurheartj/ehaa612
doi: 10.1093/eurheartj/ehaa612
Kranert M, Shchetynska-Marinova T, Liebe V, Doesch C, Papavassiliu T, Akin I, Borggrefe M, Hohneck A (2020) Recurrence of atrial fibrillation in dependence of left atrial volume index. In Vivo 34:889–896. https://doi.org/10.21873/invivo.11854
doi: 10.21873/invivo.11854
pubmed: 32111800
pmcid: 7157897
Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, Dominic P (2018) Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace 20:33–42. https://doi.org/10.1093/europace/eux013
doi: 10.1093/europace/eux013
pubmed: 28444307
Ikenouchi T, Inaba O, Takamiya T, Inamura Y, Sato A, Matsumura Y, Sato H, Hirakawa A, Takahashi Y, Goya M, Sasano T, Nitta J (2021) The impact of left atrium size on selection of the pulmonary vein isolation method for atrial fibrillation: cryoballoon or radiofrequency catheter ablation. Am Heart J 231:82–92. https://doi.org/10.1016/j.ahj.2020.10.061
doi: 10.1016/j.ahj.2020.10.061
pubmed: 33098808
Pathan F, D’Elia N, Nolan MT, Marwick TH, Negishi K (2017) Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr 30:59–70.e8. https://doi.org/10.1016/j.echo.2016.09.007
doi: 10.1016/j.echo.2016.09.007
pubmed: 28341032
Hauser R, Nielsen AB, Skaarup KG, Lassen MCH, Duus LS, Johansen ND, Sengelov M, Marott JL, Jensen G, Schnohr P, Sogaard P, Mogelvang R, Biering-Sorensen T (2021) Left atrial strain predicts incident atrial fibrillation in the general population: the Copenhagen City Heart Study. Eur Heart J Cardiovasc Imaging 23:52–60. https://doi.org/10.1093/ehjci/jeab202
doi: 10.1093/ehjci/jeab202
pubmed: 34632488
von Roeder M, Blazek S, Rommel K‑P, Kresoja K‑P, Gioia G, Mentzel L, Lurz JA, Besler C, Fengler K, Hindricks G, Desch S, Thiele H, Lurz P (2022) Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure. Clin Res Cardiol 111:1028–1039. https://doi.org/10.1007/s00392-021-01982-0
doi: 10.1007/s00392-021-01982-0
Kuppahally SS, Akoum N, Badger TJ, Burgon NS, Haslam T, Kholmovski E, Macleod R, McGann C, Marrouche NF (2010) Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. Am Heart J 160:877–884. https://doi.org/10.1016/j.ahj.2010.07.003
doi: 10.1016/j.ahj.2010.07.003
pubmed: 21095275
pmcid: 2995281
Nielsen AB, Skaarup KG, Hojbjerg Lassen MC, Djernaes K, Hansen ML, Svendsen JH, Johannessen A, Hansen J, Sorensen SK, Gislason G, Biering-Sorensen T (2020) Usefulness of left atrial speckle tracking echocardiography in predicting recurrence of atrial fibrillation after radiofrequency ablation: a systematic review and meta-analysis. Int J Cardiovasc Imaging 36:1293–1309. https://doi.org/10.1007/s10554-020-01828-2
doi: 10.1007/s10554-020-01828-2
pubmed: 32248332
Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, Lederlin M, Mondillo S, Edvardsen T, Sitges M, Grapsa J, Garbi M, Senior R, Gimelli A, Potpara TS, Van Gelder IC, Gorenek B, Mabo P, Lancellotti P, Kuck KH, Popescu BA, Hindricks G, Habib G, Cardim NM, Cosyns B, Delgado V, Haugaa KH, Muraru D, Nieman K, Boriani G, Cohen A (2016) EACVI/EHRA expert consensus document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging 17:355–383. https://doi.org/10.1093/ehjci/jev354
doi: 10.1093/ehjci/jev354
pubmed: 26864186
Porter TR, Mulvagh SL, Abdelmoneim SS, Becher H, Belcik JT, Bierig M, Choy J, Gaibazzi N, Gillam LD, Janardhanan R, Kutty S, Leong-Poi H, Lindner JR, Main ML, Mathias W, Park MM, Senior R, Villanueva F (2018) Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American society of echocardiography guidelines update. J Am Soc Echocardiogr 31:241–274. https://doi.org/10.1016/j.echo.2017.11.013
doi: 10.1016/j.echo.2017.11.013
pubmed: 29502588
Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GYH, Bollmann A (2013) Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2- VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 6:868–874. https://doi.org/10.1161/circep.113.000869
doi: 10.1161/circep.113.000869
pubmed: 24047706
Bernhardt P, Schmidt H, Hammerstingl C, Lüderitz B, Omran H (2005) Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 45:1807–1812. https://doi.org/10.1016/j.jacc.2004.11.071
doi: 10.1016/j.jacc.2004.11.071
pubmed: 15936610
Duncker D, Sommer P, Busch S, Tilz RR, Althoff T, Iden L, Metzner A, Rillig A, Chun KRJ, Bourier F, Maurer T, Shin DI (2021) Punktionstechniken in der invasiven Elektrophysiologie. Herzschr Elektrophys 32:274–284. https://doi.org/10.1007/s00399-021-00761-8
doi: 10.1007/s00399-021-00761-8
Vahanian A, Brochet E (2017) Transseptal puncture for structural heart intervention: an old technique with new indications. Heart 103:1830–1837. https://doi.org/10.1136/heartjnl-2016-310483
doi: 10.1136/heartjnl-2016-310483
pubmed: 28883033
Alkhouli M, Rihal CS, Holmes DR (2016) Transseptal techniques for emerging structural heart interventions. J Am Coll Cardiol Intv 9:2465–2480. https://doi.org/10.1016/j.jcin.2016.10.035
doi: 10.1016/j.jcin.2016.10.035
Hagendorff A, Helfen A, Flachskampf FA, Ewen S, Kruck S, La Rosée K, Knierim J, Voigt JU, Kreidel F, Fehske W, Brandt R, Zahn R, Knebel F (2021) Manual zur Indikation und Durchführung spezieller echokardiographischer Anwendungen. Kardiologe 15:595–641. https://doi.org/10.1007/s12181-021-00509-1
doi: 10.1007/s12181-021-00509-1
Alkhouli M, Sarraf M, Zack CJ, Holmes DR, Rihal CS (2016) Iatrogenic atrial septal defect following transseptal cardiac interventions. Int J Cardiol 209:142–148. https://doi.org/10.1016/j.ijcard.2016.02.068
doi: 10.1016/j.ijcard.2016.02.068
pubmed: 26894464
Hammerstingl C, Lickfett L, Jeong K‑M, Troatz C, Wedekind J‑A, Tiemann K, Lüderitz B, Lewalter T (2006) Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk? Am Heart J 152:362.e1–362.e5. https://doi.org/10.1016/j.ahj.2006.04.034
doi: 10.1016/j.ahj.2006.04.034
pubmed: 16875923
Baumgartner H, de Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G‑P, Iung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, ESC Scientific Document Group and others (2021) ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42:563–645. https://doi.org/10.1093/eurheartj/ehaa554
doi: 10.1093/eurheartj/ehaa554
pubmed: 32860028
Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang Y, American Society of Echocardiography Society for Cardiac Angiography and Interventions (2015) Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 28:910–958. https://doi.org/10.1016/j.echo.2015.05.015
doi: 10.1016/j.echo.2015.05.015
pubmed: 26239900
Lellouche N, Sebag FA, Elbaz N, Hassine M, Chaachoui N, Teiger E, Dubois-Randé J‑L, Lim P (2011) Acute pericardial effusion following atrial fibrillation ablation: characteristics and relationship with arrhythmia recurrences. Arch Cardiovasc Dis 104:450–457. https://doi.org/10.1016/j.acvd.2011.05.005
doi: 10.1016/j.acvd.2011.05.005
pubmed: 21944147
Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim Y‑H, Klein G, Packer D, Skanes A (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100–1105. https://doi.org/10.1161/01.CIR.0000157153.30978.67
doi: 10.1161/01.CIR.0000157153.30978.67
pubmed: 15723973
Tsang TSM, Freeman WK, Sinak LJ, Seward JB (1998) Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc 73:647–652. https://doi.org/10.1016/S0025-6196(11)64888-X
doi: 10.1016/S0025-6196(11)64888-X
pubmed: 9663193
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabes JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo J‑C, Delgado V, Diller G‑P, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylen I, Tolosana JM, ESC Scientific Document Group (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42:3427–3520. https://doi.org/10.1093/eurheartj/ehab364
doi: 10.1093/eurheartj/ehab364
pubmed: 34455430
Stankovic I, Prinz C, Ciarka A, Daraban AM, Kotrc M, Aarones M, Szulik M, Winter S, Belmans A, Neskovic AN, Kukulski T, Aakhus S, Willems R, Fehske W, Penicka M, Faber L, Voigt J‑U (2016) Relationship of visually assessed apical rocking and septal flash to response and long-term survival following cardiac resynchronization therapy (PREDICT-CRT). Eur Heart J Cardiovasc Imaging 17:262–269. https://doi.org/10.1093/ehjci/jev288
doi: 10.1093/ehjci/jev288
pubmed: 26588984
Voigt J‑U Assessment of MEchaNical Dyssynchrony as Selection Criterion for Cardiac Resynchronization Therapy. ClinicalTrials.gov Identifier: NCT04225520. https://classic.clinicaltrials.gov/ct2/show/NCT04225520
Coleman HN 3rd, Taylor RR, Pool PE, Whipple GH, Covell JW, Ross J Jr, Braunwald E (1971) Congestive heart failure following chronic tachycardia. Am Heart J 81:790–798. https://doi.org/10.1016/0002-8703(71)90083-4
doi: 10.1016/0002-8703(71)90083-4
pubmed: 5088355
Cruz FE, Cheriex EC, Smeets JL, Atié J, Peres AK, Penn OC, Brugada P, Wellens HJ (1990) Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol 16:739–744. https://doi.org/10.1016/0735-1097(90)90368-y
doi: 10.1016/0735-1097(90)90368-y
pubmed: 2387945
Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero I, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Moonen M, Penicka M, Ozyigit T, Carbonero JDR, van de Veire N, von Bardeleben RS, Vinereanu D, Zamorano JL, Go YY, Rosca M, Calin A, Magne J, Cosyns B, Marchetta S, Donal E, Habib G, Galderisi M, Badano LP, Lang RM, Lancellotti P (2017) Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 18:833–840. https://doi.org/10.1093/ehjci/jex140
doi: 10.1093/ehjci/jex140
pubmed: 28637227
Kusunose K, Torii Y, Yamada H, Nishio S, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Tobiume T, Yagi S, Soeki T, Wakatsuki T, Sata M (2017) Clinical utility of longitudinal strain to predict functional recovery in patients with tachyarrhythmia and reduced LVEF. JACC Cardiovasc Imaging 10:118–126. https://doi.org/10.1016/j.jcmg.2016.03.019
doi: 10.1016/j.jcmg.2016.03.019
pubmed: 27665160